Poolbeg Pharma (POLB) Stock Chart & Stock Price History GBX 2.98 -0.02 (-0.50%) As of 10:53 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Poolbeg Pharma Stock Price Performance The Poolbeg Pharma (POLB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 75.80%, with a year-to-date return of -57.96%. In the past month, the stock has decreased 5.24%, reflecting recent market activity. As of the latest close, Poolbeg Pharma traded at GBX 3.07 with a market cap of £15.78 million and volume of 597,512 shares. Receive POLB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Poolbeg Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+17.84%1 Month Performance-5.24%3 Month Performance+2.93%Year-To-Date Performance-57.96%1 Year Performance-75.80% POLB Stock Chart for Thursday, August, 14, 2025 POLB Chart by TradingView Poolbeg Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/13/2025GBX 2.95GBX 3.07+4.07%GBX 3.07GBX 2.90597,512 shs£15.78 million08/12/2025GBX 2.86GBX 2.95+3.15%GBX 3.08GBX 2.803.06 million shs£15.16 million08/11/2025GBX 2.53GBX 2.86+12.91%GBX 2.86GBX 2.503.35 million shs£14.70 million08/08/2025GBX 2.60GBX 2.53-2.58%GBX 2.60GBX 2.501.98 million shs£13.02 million08/07/2025GBX 2.55GBX 2.60+2.00%GBX 2.60GBX 2.50374,550 shs£13.36 million08/06/2025GBX 2.61GBX 2.55-2.26%GBX 2.67GBX 2.501.50 million shs£13.10 million08/05/2025GBX 2.60GBX 2.61+0.15%GBX 2.70GBX 2.501.68 million shs£13.40 million08/04/2025GBX 2.71GBX 2.60-3.91%GBX 2.62GBX 2.502.19 million shs£13.38 million08/01/2025GBX 2.69GBX 2.71+0.74%GBX 2.80GBX 2.60319,659 shs£13.93 million07/31/2025GBX 2.70GBX 2.69-0.37%GBX 2.70GBX 2.60401,240 shs£13.83 million Get the Latest News and Ratings for POLB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Poolbeg Pharma and its competitors with MarketBeat's FREE daily newsletter. 07/30/2025GBX 2.67GBX 2.70+1.31%GBX 2.70GBX 2.60810,589 shs£13.88 million07/29/2025GBX 2.80GBX 2.67-4.82%GBX 2.80GBX 2.60745,049 shs£13.70 million07/28/2025GBX 2.90GBX 2.80-3.45%GBX 2.80GBX 2.65706,967 shs£14.39 million07/25/2025GBX 2.89GBX 2.90+0.35%GBX 3GBX 2.705.06 million shs£14.91 million07/24/2025GBX 3.07GBX 2.89-5.80%GBX 3.20GBX 2.606.83 million shs£14.85 million07/23/2025GBX 3GBX 3.07+2.20%GBX 3.20GBX 3646,177 shs£15.77 million07/22/2025GBX 3GBX 3+0.07%GBX 3.20GBX 3457,143 shs£15.43 million07/21/2025GBX 3.08GBX 3-2.60%GBX 3.18GBX 3648,701 shs£15.42 million07/18/2025GBX 3GBX 3.08+2.67%GBX 3.20GBX 31.41 million shs£15.83 million07/17/2025GBX 3.15GBX 3-4.76%GBX 3.10GBX 32.07 million shs£15.42 million07/16/2025GBX 3.20GBX 3.15-1.56%GBX 3.20GBX 3.101.53 million shs£16.19 million07/15/2025GBX 3.15GBX 3.20+1.59%GBX 3.20GBX 3.101.25 million shs£16.45 million07/14/2025GBX 3.20GBX 3.15-1.56%GBX 3.27GBX 3.151.21 million shs£16.19 million Related Companies SBTX Stock Chart FUM Stock Chart TRX Stock Chart AREC Stock Chart SAR Stock Chart FAB Stock Chart IXI Stock Chart APTA Stock Chart OPTI Stock Chart OBD Stock Chart Receive POLB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Poolbeg Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (LON:POLB) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredTesla is in troubleThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poolbeg Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Poolbeg Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access